抗肿瘤抗生素与抗体工程技术的结合可以作为新的技术平台，制备一系列的针对不同靶点的、用于治疗癌症的抗体靶向药物。
The integration of antitumor antibiotic and antibody engineering can serve as new technical platform for manufacture of a series of various target-specific antibody-based drugs for cancer therapy.
此外，发现用于治疗HER 2阳性乳腺癌的药物赫赛汀，能够靶向和摧毁癌症干细胞。
Further, the drug Herceptin, which is used to treat HER2-positive breast cancer, was found to target and destroy the cancer stem cells.
研究人员认为新药靶向治疗癌症是这项研究的重要应用。
The researchers agree that identifying targets for new drugs will be an important application of these findings.
应用推荐